Pages that link to "Q28247388"
Jump to navigation
Jump to search
The following pages link to BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition (Q28247388):
Displaying 50 items.
- Drugging MYCN through an allosteric transition in Aurora kinase A (Q24303381) (← links)
- ATM activation by ionizing radiation requires BRCA1-associated BAAT1 (Q24303405) (← links)
- Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73 (Q24305327) (← links)
- The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors (Q24306302) (← links)
- Phosphorylation and stabilization of HURP by Aurora-A: implication of HURP as a transforming target of Aurora-A (Q24306319) (← links)
- Aurora A, centrosome structure, and the centrosome cycle (Q24318115) (← links)
- Plk1 regulates mitotic Aurora A function through betaTrCP-dependent degradation of hBora (Q24318919) (← links)
- BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution (Q25255829) (← links)
- New concepts on BARD1: Regulator of BRCA pathways and beyond (Q26770424) (← links)
- Aurora-A Kinase as a Promising Therapeutic Target in Cancer (Q26771371) (← links)
- Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review (Q26783412) (← links)
- Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale (Q26851529) (← links)
- Aurora kinase A in gastrointestinal cancers: time to target (Q26864277) (← links)
- Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients (Q27853386) (← links)
- PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer (Q28118057) (← links)
- Is there more to BARD1 than BRCA1? (Q28236135) (← links)
- Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155 (Q28249114) (← links)
- Network modeling links breast cancer susceptibility and centrosome dysfunction (Q28252491) (← links)
- Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression (Q28264994) (← links)
- The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly (Q28271991) (← links)
- From midbody protein-protein interaction network construction to novel regulators in cytokinesis (Q28596600) (← links)
- Aurora-A interacts with AP-2α and down regulates its transcription activity (Q28741932) (← links)
- The BRCA1 E3 ubiquitin ligase controls centrosome dynamics (Q33343140) (← links)
- Aurora kinases: novel therapy targets in cancers (Q33618929) (← links)
- The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy (Q33637754) (← links)
- Aurora kinase inhibitors--rising stars in cancer therapeutics? (Q33647643) (← links)
- Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A. (Q34026716) (← links)
- Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer (Q34081324) (← links)
- Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. (Q34095173) (← links)
- Danusertib, an aurora kinase inhibitor (Q34126899) (← links)
- Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation (Q34186981) (← links)
- Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease. (Q34355892) (← links)
- Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients (Q34491749) (← links)
- Roles of Aurora kinases in mitosis and tumorigenesis. (Q34574449) (← links)
- Update on aurora kinase inhibitors in gynecologic malignancies (Q34576017) (← links)
- Aurora kinases: new targets for cancer therapy (Q34587271) (← links)
- Missense variants of uncertain significance (VUS) altering the phosphorylation patterns of BRCA1 and BRCA2. (Q34737253) (← links)
- Efficient prediction of human protein-protein interactions at a global scale. (Q34746808) (← links)
- Issues in interpreting the in vivo activity of Aurora-A (Q34964087) (← links)
- AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma (Q35154633) (← links)
- Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancer (Q35596953) (← links)
- MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells (Q35784718) (← links)
- Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase (Q35801868) (← links)
- Role of BRCA1 in controlling mitotic arrest in ovarian cystadenoma cells (Q35822970) (← links)
- Aurora kinase inhibitors as anticancer molecules (Q35850203) (← links)
- Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells. (Q35850229) (← links)
- Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1 (Q35924811) (← links)
- BRCA2: breaks, mistakes and failed separations (Q36095345) (← links)
- Aurora kinases, aneuploidy and cancer, a coincidence or a real link? (Q36113247) (← links)
- Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome. (Q36166792) (← links)